Vecnost Biotechnology Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 16-11-2024
- Paid Up Capital ₹ 5.00 M
as on 16-11-2024
- Company Age 3 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.65 Cr
as on 16-11-2024
- Satisfied Charges ₹ 2.00 M
as on 16-11-2024
- Revenue %
(FY 2023)
- Net Worth 4031.13%
(FY 2023)
- Total Assets 98.55%
(FY 2023)
About Vecnost Biotechnology
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹1.65 Cr. The company has closed loans amounting to ₹2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Krishna Kumari and Kamal Sharma serve as directors at the Company.
- CIN/LLPIN
U24290PB2021PTC053235
- Company No.
053235
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Apr 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Tarn Taran, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Vecnost Biotechnology?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Kumari  | Director | 24-May-2021 | Current |
| Kamal Sharma | Director | 16-Apr-2021 | Current |
Financial Performance of Vecnost Biotechnology.
Vecnost Biotechnology Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth Soared by an impressive increase of 4031.13%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Vecnost Biotechnology?
Unlock access to Vecnost Biotechnology's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 22 Dec 2021 | ₹1.65 Cr | Open |
Others Creation Date: 05 May 2023 | ₹2.00 M | Satisfied |
How Many Employees Work at Vecnost Biotechnology?
Unlock and access historical data on people associated with Vecnost Biotechnology, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vecnost Biotechnology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vecnost Biotechnology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
